Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients.

Kong L, Gu X

Open source

DOI
10.5414/cp204936
Published
2026 Sep 10
Container
International journal of clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5414/cp204936,
  title = {Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients.},
  author = {Kong L and Gu X},
  year = {2026},
  journal = {International journal of clinical pharmacology and therapeutics},
  doi = {10.5414/cp204936},
  url = {https://doi.org/10.5414/cp204936}
}

RIS

TY  - JOUR
TI  - Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients.
AU  - Kong L
AU  - Gu X
PY  - 2026
JO  - International journal of clinical pharmacology and therapeutics
DO  - 10.5414/cp204936
UR  - https://doi.org/10.5414/cp204936
ER  - 

APA

L, K., & X, G. (2026). Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients.. International journal of clinical pharmacology and therapeutics. https://doi.org/10.5414/cp204936

Source records